Thats the beauty of our bavituximab; safe, efficacious and can be combined with ALL oncology treatments! I/O space is only a quarter of the game imo bavituximab will be used in ALL therapies chemo, I/O, radiation and surgery within the next five years.
The value is going to reset when we least expect it. A lot of news coming in April imo we have AACR and an initiation of the PD1 combo trial. Do we hear news of first look in?